Abiogen Pharma.

This is actually the fourth orphan medication we have licensed-in and it once again demonstrates our dedication to rare diseases. .. Abiogen Pharma, Lee’s Pharma sign deal to advertise Neridronic Acid Abiogen Pharma S.p.A. Beneath the term of the agreement, Abiogen Pharma S.p.A. Neridronate may be the only therapeutic agent accepted in the world for such orphan diseases: OI and CRPS . Neridronate showed excellent safety profile in long-term use and is certainly tolerated by adults and pediatric population highly. It is the only bisphosphonate indicated for make use of in neonates and kids. Dr. Massimo Di Martino, President & CEO of Abiogen Pharma stated: I am happy to discover that Neridronate could cross political and geographic barriers to advantage the sufferers.Adeona’s HartLab expands diagnostic screening services to include full array of microbiology testing Adeona Pharmaceuticals, Inc. announced that its wholly-owned CLIA-certified clinical tests subsidiary, HartLab, has expanded its in-house diagnostic testing services to include a full array of microbiology assessment. Microbiology testing carries a broad array of tests for the identification and sensitivity testing of the causative agents of infectious diseases followed by prompt, accurate reporting of results.